Certified by Founder Lodge
KdT Ventures
United States - Austin
INVESTOR
1 Disclosed Funding Rounds $200,000,000
17 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
KdT Ventures is a new age seed stage venture firm, with a focus on the intersection of technology and science. Our thesis is that advances in compute are allowing us to solve problems never b
| Company | Date | Round | Raised |
|---|---|---|---|
Reverb Therapeutics |
February, 21 ,2025 | Seed | $21,000,000 |
Asimov |
January, 09 ,2023 | Series B | $200,000,000 |
Marigold Health |
June, 18 ,2024 | Series A | $11,000,000 |
Character Biosciences |
March, 27 ,2025 | Series B | $39,000,000 |
Dimension Inx |
February, 02 ,2023 | Unknown | $12,000,000 |
Faeth Therapeutics |
October, 21 ,2025 | Unknown | $25,000,000 |
Reverb Therapeutics |
February, 21 ,2025 | Seed | $21,000,000 |
Molecule |
July, 01 ,2022 | Seed | $12,700,000 |
SURGE Therapeutics |
July, 20 ,2023 | Series B | $32,000,000 |
Aperiam Bio |
November, 30 ,2023 | Seed | $9,000,000 |
ZymoChem |
January, 17 ,2024 | Series A | $21,000,000 |
Motif Neurotech |
January, 25 ,2024 | Series A | $18,750,000 |
ELEGEN |
May, 16 ,2024 | Series B | $35,000,000 |
Marigold Health |
June, 18 ,2024 | Series A | $11,000,000 |
Reverb Therapeutics |
February, 21 ,2025 | Seed | $21,000,000 |
Character Biosciences |
March, 27 ,2025 | Series B | $39,000,000 |
Faeth Therapeutics |
October, 21 ,2025 | Unknown | $25,000,000 |
Reverb Therapeutics
Asimov
Marigold Health
Character Biosciences
Dimension Inx
Faeth Therapeutics
Molecule
SURGE Therapeutics
Aperiam Bio
ZymoChem
Motif Neurotech
ELEGEN
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)